Search clinical trials for: Glucagon

Total 762 results

The University of Texas Health Science Center,...

Recruiting

Semaglutide for Post-Smoking Cessation Weight Management

Obesity | Overweight | Cigarette Smoking

United States
University of Chicago

Not yet recruiting

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Multiple Sclerosis | Obesity | Obesity, Morbid | Obese | Long COVID | Long Covid19 | Acute Leukemia in Remission
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Imperial College London

Not yet recruiting

Liver Fat and Glucagon Resistance

Steatosis of Liver
Second Xiangya Hospital of Central South University

Recruiting

Subcutaneous Semaglutide in Systemic Scleroderma

Fibrosis | Scleroderma, Systemic | Semaglutide

China
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Recruiting

Neuronostatin - a Glucagonotropic Agent in Humans? (NSTCLAMP)

Hypoglycemia | Type1diabetes | Type 1 Diabetes

Denmark
Pichamol Jirapinyo, MD, MPH

Not yet recruiting

ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial

Liver Diseases | Metabolic Diseases | Obesity | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Insulin Resistance | Weight Loss | Liver Fat | NAFLD | Insulin Sensitivity/Resistance | Insulin Sensitivity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non Alcoholic Fatty... and other conditions

United States
University of Missouri-Columbia
American Society for Metabolic and Bariatric Surgery

Recruiting

Impact GLP-1 Agonists Following Bariatric

Hypertension | Diabetes Mellitus | Metabolic Syndrome | Morbid Obesity | Obstructive Sleep Apnea of Adult

United States
Novo Nordisk A/S

Recruiting

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

Obesity | Type 2 Diabetes | Chronic Kidney Disease

United States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Slovakia, Hungary, Brazil
Novo Nordisk A/S

Recruiting

A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight

Obesity

United States
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...

Not yet recruiting

Dexamethasone/Pancreatic Clamp P&F

Insulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver Disease

United States
Universitat Politècnica de Valéncia
Hospital Clínico Universitario de Valencia

Recruiting

Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge (TAILOR/3)

Type 1 Diabetes

Spain
Rutgers, The State University of New Jersey
Alzheimer's Association

Recruiting

COMMETS- Combination MCI Metabolic Syndrome

Metabolic Syndrome | Alzheimer Disease | Mild Cognitive Impairment

Israel
Brigham and Women's Hospital
Charles A. King Trust Postdoctoral Fellowship Program

Not yet recruiting

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Overweight and Obesity
Novo Nordisk A/S

Recruiting

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor (REIMAGINE 2)

Type 2 Diabetes Mellitus

Korea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, India, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
Odense University Hospital

Recruiting

The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial

Type 2 Diabetes | Osteopenia

Denmark
Eli Lilly and Company

Recruiting

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin (ACHIEVE-3)

Type 2 Diabetes

United States, China, Japan, Argentina, Puerto Rico, Mexico
Novo Nordisk A/S

Recruiting

A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range (STEP12)

Obesity | Overweight

China, Taiwan
University of North Carolina, Chapel Hill

Recruiting

Using Point-of-Care-Ultrasound (POCUS) to Assess Gastric Contents Among Fasting Pre-operative Patients Taking GLP-1 Agonists.

Gastroparesis | Delayed Gastric Emptying

United States
Helse Stavanger HF
Oslo University Hospital; Haukeland University Hospital; St. Olavs Hospital; Alesund... and other collaborators

Recruiting

Antibiotics, Microbiology and Immunology in Children With Chronic Wet Cough - the AMIC Study (AMIC)

Protracted Bacterial Bronchitis

Norway
National Institute on Drug Abuse (NIDA)

Recruiting

Semaglutide Therapy for Alcohol Reduction (STAR)

Addiction | Alcohol Use Disorder

United States
Hospital for Special Surgery, New York

Recruiting

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Glucagon-like Peptide 1 | Gastric Ultrasound | Point of Care Ultrasound

United States, Canada
Massachusetts General Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH (GLUCOSE-MGH)

Metabolic Diseases | Type 2 Diabetes | Genetic Predisposition

United States
Novo Nordisk A/S

Recruiting

A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight (REDEFINE 6)

Obesity or Overweight

China
University of Cincinnati

Recruiting

Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes

Hypoglycemia | type1diabetes

United States
St. Olavs Hospital

Recruiting

Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1

Type 1 Diabetes

Norway
University Health Network, Toronto

Recruiting

The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK)

Kidney Transplant Recipients

Canada
Chinese University of Hong Kong
Linyi People's Hospital

Recruiting

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke Treated by Reperfusion Therapies (GALLOP)

Stroke | Brain Diseases | Stroke, Ischemic | Stroke, Acute

Hong Kong, China
Psychiatric Centre Rigshospitalet
Neurobiology Research Unit

Recruiting

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity? (SEMALCO)

Alcohol Dependence | Alcohol Use Disorder | Alcohol Abuse | Alcohol Addiction

Denmark
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Non-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, Nonalcoholic

Canada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo... and more
Washington University School of Medicine
Novo Nordisk A/S

Not yet recruiting

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Endometrial Hyperplasia

United States
University of Washington
University of Colorado, Denver; Juvenile Diabetes Research Foundation; University... and other collaborators

Recruiting

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes (RT1D)

Type 1 Diabetes | Diabetic Kidney Disease

United States, Canada
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)

Diabetes Mellitus, Type 1

United States
University of Colorado, Denver
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome (RESTORE)

Obese | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

United States
Novo Nordisk A/S

Recruiting

A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Thailand, Poland, Czechia, Malaysia, Serbia
Novo Nordisk A/S

Recruiting

A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight

Obesity or Overweight

Taiwan, Japan
Wuhan Union Hospital, China
Peking University First Hospital

Recruiting

High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

Cardiovascular Diseases | Coronary Disease | Diabetes Mellitus, Type 2

China
University of Washington
Novo Nordisk A/S

Recruiting

Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Diabetes Mellitus, Type 2 | Stroke (CVA) or Transient Ischemic Attack

United States
RenJi Hospital

Recruiting

Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Obesity, Abdominal | Non-Alcoholic Fatty Liver Disease | Metabolism Disorder, Glucose | Metabolism Disorder, Lipid | Metformin | Abdominal Fat

China
Louisiana State University Health Sciences Center...
Tulane University; Pennington Biomedical Research Center; Ochsner Health System

Recruiting

Anti-obesity Pharmacotherapy and Inflammation

Obesity

United States
Dr Adnan Agha

Recruiting

Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue

Liver Fat | Type 2 Diabetes | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

United Arab Emirates
Novo Nordisk A/S

Recruiting

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight (STEP Young)

Obesity

Belgium, United Kingdom, United States, Sweden, Portugal, Austria, Germany, Israel, Mexico, Denmark
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...

Recruiting

Pancreatic Clamp in NAFLD

Obesity | Insulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver Disease

United States
Novo Nordisk A/S

Not yet recruiting

Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2
Peking University First Hospital

Recruiting

Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome

Semaglutide | PCOS (Polycystic Ovary Syndrome)

China
Novo Nordisk A/S

Recruiting

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels (REDEFINE 3)

Cardiovascular Disease

Netherlands, Australia, Italy, United States, Serbia, Malaysia, Spain, United Kingdom, Thailand, India, Turkey, Mexico, Canada, Bulgaria, Argentina, Germany, France, Poland, South Africa, Brazil, Colombia, Denmark, Ireland, Japan
AstraZeneca

Not yet recruiting

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED)

Pancreatic Cancer
University of Hull

Not yet recruiting

Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

United Kingdom
University of Exeter
Royal Devon and Exeter NHS Foundation Trust

Recruiting

Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes (MUGGLE)

Hypoglycemia | Type 1 Diabetes

United Kingdom
University of Nottingham
Medical Research Council

Recruiting

Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets (SemVLCD)

Type 2 Diabetes Mellitus in Obese

United Kingdom

Search clinical trials for: Glucagon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations